PL3581199T3 - Sposoby leczenia lub zmniejszania panikulopatii obrzękowo- zwłóknieniowo-stwardnieniowej - Google Patents

Sposoby leczenia lub zmniejszania panikulopatii obrzękowo- zwłóknieniowo-stwardnieniowej

Info

Publication number
PL3581199T3
PL3581199T3 PL19172643.9T PL19172643T PL3581199T3 PL 3581199 T3 PL3581199 T3 PL 3581199T3 PL 19172643 T PL19172643 T PL 19172643T PL 3581199 T3 PL3581199 T3 PL 3581199T3
Authority
PL
Poland
Prior art keywords
paniculopathy
edemated
fibrosclerosis
treating
reducing
Prior art date
Application number
PL19172643.9T
Other languages
English (en)
Inventor
Susan G. Emeigh Hart
Original Assignee
Endo Global Ventures
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Global Ventures filed Critical Endo Global Ventures
Publication of PL3581199T3 publication Critical patent/PL3581199T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24003—Microbial collagenase (3.4.24.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL19172643.9T 2011-10-21 2012-10-19 Sposoby leczenia lub zmniejszania panikulopatii obrzękowo- zwłóknieniowo-stwardnieniowej PL3581199T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161549863P 2011-10-21 2011-10-21

Publications (1)

Publication Number Publication Date
PL3581199T3 true PL3581199T3 (pl) 2023-09-11

Family

ID=48141393

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19172643.9T PL3581199T3 (pl) 2011-10-21 2012-10-19 Sposoby leczenia lub zmniejszania panikulopatii obrzękowo- zwłóknieniowo-stwardnieniowej

Country Status (14)

Country Link
US (2) US20140335072A1 (pl)
EP (2) EP2768523B1 (pl)
JP (5) JP2014530873A (pl)
AU (6) AU2012325941A1 (pl)
BR (1) BR112014009785B1 (pl)
CA (1) CA2852942C (pl)
DK (2) DK2768523T3 (pl)
ES (2) ES2953560T3 (pl)
FI (1) FI3581199T3 (pl)
HU (2) HUE044650T2 (pl)
MX (2) MX2014004792A (pl)
PL (1) PL3581199T3 (pl)
PT (2) PT3581199T (pl)
WO (1) WO2013059619A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4015627B1 (en) 2012-01-12 2023-09-27 Endo Global Ventures Clostridium histolyticum enzyme
CN104271152B (zh) 2012-05-01 2016-08-17 普罗泰奥里斯有限公司 拔出牙齿的方法
US9744138B2 (en) 2013-03-15 2017-08-29 Biospecifics Technologies Corp. Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) * 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
EP4591945A2 (en) 2017-03-01 2025-07-30 Endo Operations Limited Apparatus and method for assessing and treating cellulite
US11473074B2 (en) * 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
WO2020021332A2 (en) * 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020021330A2 (en) * 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
MX2021000901A (es) * 2018-07-23 2021-06-18 Revelle Aesthetics Inc Sistema y metodos de tratamiento de celulitis.
AU2019341663C1 (en) * 2018-09-18 2025-08-07 Endo Global Aesthetics Limited Compositions and methods for treating cellulite
WO2020142701A1 (en) * 2019-01-06 2020-07-09 Endo Global Aesthetics Limited Collagenase formulations and methods of producing the same
US11872267B2 (en) 2019-10-15 2024-01-16 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase
EP3861948A1 (en) * 2020-02-10 2021-08-11 Daniel A. Del Vecchio Cellulite eradication methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645668A (en) 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US6958150B2 (en) * 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
EP3424508B1 (en) * 2004-05-19 2021-05-05 Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Use of sodium deoxycholate for the removal of localized fat accumulation
US20070224184A1 (en) 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2007100590A2 (en) * 2006-02-22 2007-09-07 Auxilium Pharmaceuticals, Inc. Methods for treating cellulite
CN102784387A (zh) * 2007-02-14 2012-11-21 友莱尔皮肤产品有限责任公司 修饰的突变体胶原蛋白酶及其在脂肪溶解和疤痕减少中的应用

Also Published As

Publication number Publication date
ES2953560T3 (es) 2023-11-14
JP2014530873A (ja) 2014-11-20
AU2012325941A1 (en) 2014-05-15
EP3581199A1 (en) 2019-12-18
BR112014009785A8 (pt) 2020-02-27
HUE063599T2 (hu) 2024-01-28
FI3581199T3 (fi) 2023-08-18
PT3581199T (pt) 2023-08-31
HUE044650T2 (hu) 2019-11-28
MX392388B (es) 2025-03-24
JP2022123073A (ja) 2022-08-23
HK1201439A1 (en) 2015-09-04
DK2768523T3 (da) 2019-07-22
JP2018027968A (ja) 2018-02-22
EP2768523A1 (en) 2014-08-27
NZ722722A (en) 2019-05-31
DK3581199T3 (da) 2023-09-04
AU2017248451A1 (en) 2017-11-02
MX2019007779A (es) 2019-09-04
PT2768523T (pt) 2019-08-29
JP2024123126A (ja) 2024-09-10
CA2852942A1 (en) 2013-04-25
WO2013059619A1 (en) 2013-04-25
US20140335072A1 (en) 2014-11-13
AU2022202987A1 (en) 2022-05-26
AU2020200763A1 (en) 2020-02-20
EP3581199B1 (en) 2023-05-31
US20240216485A1 (en) 2024-07-04
NZ759819A (en) 2020-11-27
EP2768523A4 (en) 2015-04-22
ES2741476T3 (es) 2020-02-11
AU2016202026A1 (en) 2016-04-21
EP2768523B1 (en) 2019-05-22
NZ737403A (en) 2020-05-29
AU2017248451B2 (en) 2019-11-14
NZ624057A (en) 2016-08-26
CA2852942C (en) 2023-01-10
BR112014009785B1 (pt) 2020-06-30
AU2022202987B2 (en) 2025-03-20
AU2025204462A1 (en) 2025-07-03
AU2020200763B2 (en) 2022-05-26
MX2014004792A (es) 2015-08-14
BR112014009785A2 (pt) 2017-04-25
JP2020158521A (ja) 2020-10-01
NZ769098A (en) 2022-03-25

Similar Documents

Publication Publication Date Title
PL3581199T3 (pl) Sposoby leczenia lub zmniejszania panikulopatii obrzękowo- zwłóknieniowo-stwardnieniowej
EP2683693A4 (en) ROR-GAMMA-T INHIBITORS
CO6920291A2 (es) 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idhmutante
SMT201700109B (it) Inibitori di istone demetilasi
LT2885010T (lt) Tautopatijos gydymo būdai
SMT201600108B (it) Derivato di pirazochinolina come inibitori di pde9
EP2723384A4 (en) TREATMENT OF PROTEINOPATHIES
EP2675909A4 (en) GLUCOSYLSTEVIA COMPOSITION
EP2720561A4 (en) Stevia-COMPOSITION
CO6960542A2 (es) Polimorfos de inhibidores de cinasas
EP2713762A4 (en) Stevia-COMPOSITION
IL227764A0 (en) Pyrrolotriazinone derivatives as pi3k inhibitors
CO7010824A2 (es) Inhibidores de aplicación viral
IL231061A0 (en) Antibacterial compounds and methods for use
SMT201600001B (it) Imidazopiridazine come inibitori di akt chinasi
BR112014013850A2 (pt) conjunto de prateleiras
EP2892536A4 (en) METHOD FOR TREATING LEUKEMIA
IL231092A0 (en) Treatment of rhinitis
BR112014000022A2 (pt) 1-3-tiazepinas ciclopropil-fundidas como inibidores de bace 1 e/ou bace 2
BR112013022820A2 (pt) método de tratamento
EP2854093A4 (en) BENEFIT SHARING METHOD FOR COOPERATIVE WORK ON CONTENT
EP2750709A4 (en) TREATMENT OF KACHEXIE
EP2797752A4 (en) CUTTING MEDIA
EP2858975A4 (en) FBXO3 INHIBITORS
EP2714694A4 (en) BAKTERIOCHLORIMIDE